Newsfeeds - Spark Newswire

5 minute read

Uncategorized

The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal

Today, 1:03 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 24)

ADVM

27 minute read

Uncategorized

Bristol Myers Squibb Says Receives Positive CHMP Opinion Recommending Opdivo (nivolumab) Plus Yervoy (ipilimumab) For Treatment Of Mismatch Repair Deficient Or Microsatellite Instability–High Metastatic Colorectal Cancer After Prior Chemotherapy

By Benzinga Newsdesk

Today, 1:03 PM

Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Opdivo (nivolumab) plus Yervoy (ipilimumab) for Treatment of Mismatch Repair Deficient or Microsatellite Instability–High Metastatic Colorectal

BMY

2 minute read

Uncategorized

Pharma/Biotech Companies Highlight Upcoming Presentations At American Society Of Clinical Oncology Jun. 4-8, 2021

By Benzinga Newsdesk

Today, 1:03 PM

Cullinan Oncology (CGEM) - https://www.globenewswire.com/news-release/2021/05/19/2232874/0/en/Cullinan-Oncology-to-Provide-CLN-081-Clinical-Update-at-ASCO-2021.html BeiGene (BGNE)

ADAP

2 minute read

Uncategorized

Cathie Wood Cuts Apple Stake Almost Entirely — And Buys More Coinbase

By Rachit Vats

Today, 1:03 PM

Cathie Wood-led Ark Investment Management on Monday shed nearly all of its stake in Apple Inc (NASDAQ: AAPL) and continued to snap up shares of Coinbase Global Inc (NASDAQ: COIN).

AAPL

2 minute read

Uncategorized

Bristol Myers Squibb Announced at AAC Expo, Mavacamten, a Potential First-in-class Cardiac Myosin Inhibitor for Patients with Symptomatic oHCM, Showed Improvement in Health Status vs placebo at 30 weeks in EXPLORER-HCM trial

By Charles Gross

Today, 1:03 PM

Bristol Myers Squibb (NYSE: BMY) today announced a new analysis of data from the Phase 3 EXPLORER-HCM study evaluating mavacamten, an investigational, first-in-class cardiac myosin inhibitor, in patients with obstructive hypertrophic cardiomyopathy (oHCM), which was presented at the American College of Cardiology's 70th Annual Sc

BMY

2 minute read

Uncategorized

The Week Ahead In Biotech: Sanofi, Bristol-Myers Squibb Await FDA Decisions, Earnings News Flow Tapers Off

By Shanthi Rexaline

Today, 1:03 PM

Biotech stocks had a volatile ride in the week ended May 14, with stocks moving broadly lower for much of the week before coming back up strongly in the final session. Some of the weakness may be traced back to the across-the-board weakness in markets, as macroeconomic fears unnerved traders.

ACRX

2 minute read

Uncategorized

Cathie Wood Sheds $33.6M Alibaba Shares On Earnings Day

By Rachit Vats

Today, 1:03 PM

Cathie Wood-led Ark Investment Management on Thursday shed 162,840 shares, worth about $33.6 million, in Alibaba Group Holding (NYSE: BABA) after the company posted its first operating loss as a listed company, as a record regulatory fine it was

ADYEY